Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Kolm, R
Human clinical application is still early, but the gene-level mechanism is well-documented
6, 1995, pp
This is highly speculative because: Oral bioavailability differs between species Route of administration affects systemic exposure Species differences in peptide metabolism and clearance are unknown Current Practice Patterns Current practice patterns from unregulated sources typically involve: Subcutaneous injection: 0.25-0.5 mg once or twice daily, administered near injection sites for localized effects or abdominally for systemic distribution
US$ 23.15
US$ 29.37
US$ 28.48
US$ 26.41
